Literature DB >> 32434159

A detailed Monte Carlo evaluation of 192Ir dose enhancement for gold nanoparticles and comparison with experimentally measured dose enhancements.

Tara Gray1, Nema Bassiri, Shaquan David, Devanshi Yogeshkumar Patel, Sotirios Stathakis, Neil Kirby, Kathryn M Mayer.   

Abstract

Gold nanoparticles (GNPs) have been studied extensively as promising radiation dose enhancing agents. In the current study, the dose enhancement effect of GNPs for Ir-192 HDR brachytherapy is studied using Monte Carlo N-Particle code, version 6.2 (MCNP6.2) and compared with experimental results obtained using Burlin cavity theory formalism. The Ir-192 source is verified using TG-43 parameters and dose enhancement factors (DEFs) from GNPs are simulated for three different mass percentages of gold in the GNP solution. These results are compared to DEFs previously reported experimentally by our group (Bassiri et al 2019 Med. Phys.) for a GNP-containing volume in an apparatus designed in-house to measure dose enhancement with GNPs for high dose rate (HDR) Ir-192 brachytherapy. An HDR Ir-192 Microselectron v2 r HDR brachytherapy source was modeled using MCNP6.2 using the TG-43 formalism in water. Anisotropy and radial dose function were verified against known values. An apparatus designed to measure dose enhancement to a 0.75 cm3 volume of GNPs from an Ir-192 brachytherapy seed with average energy of 0.38 MeV was built in-house and modeled using MCNP6.2. Burlin cavity correction factors were applied to experimental measurements. The macroscopic DEF was calculated for GNPs of size 30 nm at mass percentages of gold of 0.28%, 0.56% and 0.77%, using the repeating structures capability of MCNP6.2. DEF was calculated by dividing dose to the GNP solution by dose to water in the same volume. The radial dose function and anisotropy factor values at varying angles and distances were accurate when compared against known values. DEFs of 1.018 ± 0.003, 1.031 ± 0.003, and 1.041 ± 0.003 for GNP solutions containing mass percent of gold of 0.28%, 0.56% and 0.77%, respectively, were computed. These DEFs were within 2% of experimental values with Burlin cavity correction factors applied for all three mass percentages of gold.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32434159      PMCID: PMC7927155          DOI: 10.1088/1361-6560/ab9502

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  32 in total

1.  Size-controlled synthesis of gold nanoparticles via high-temperature reduction.

Authors:  David A Fleming; Mary Elizabeth Williams
Journal:  Langmuir       Date:  2004-04-13       Impact factor: 3.882

2.  Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2.

Authors:  Domingo Granero; Javier Vijande; Facundo Ballester; Mark J Rivard
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

Review 3.  [Brachytherapy dose calculation].

Authors:  M Ferré; H Mailleux; N Pierrat; C Dejean
Journal:  Cancer Radiother       Date:  2013-02-28       Impact factor: 1.018

4.  The use of gold nanoparticles to enhance radiotherapy in mice.

Authors:  James F Hainfeld; Daniel N Slatkin; Henry M Smilowitz
Journal:  Phys Med Biol       Date:  2004-09-21       Impact factor: 3.609

5.  Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles.

Authors:  Jong-Ki Kim; Seung-Jun Seo; Hong-Tae Kim; Ki-Hong Kim; Myung-Hwan Chung; Kye-Ryung Kim; Sung-Jun Ye
Journal:  Phys Med Biol       Date:  2012-11-30       Impact factor: 3.609

6.  Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice.

Authors:  Meng-Ya Chang; Ai-Li Shiau; Yu-Hung Chen; Chih-Jui Chang; Helen H-W Chen; Chao-Liang Wu
Journal:  Cancer Sci       Date:  2008-04-11       Impact factor: 6.716

7.  Technical Note: Film-based measurement of gold nanoparticle dose enhancement for 192 Ir.

Authors:  Nema Bassiri; Tara Gray; Shaquan David; Devanshi Yogeshkumar Patel; Andrew Locker; Karl Rasmussen; Niko Papanikolaou; Kathryn M Mayer; Neil Kirby
Journal:  Med Phys       Date:  2019-11-19       Impact factor: 4.071

8.  Photoactivation of gold nanoparticles for glioma treatment.

Authors:  Laure Bobyk; Magali Edouard; Pierre Deman; Mathias Vautrin; Karin Pernet-Gallay; Julie Delaroche; Jean-François Adam; François Estève; Jean-Luc Ravanat; Hélène Elleaume
Journal:  Nanomedicine       Date:  2013-05-01       Impact factor: 5.307

9.  Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.

Authors:  S Hashemi; M R Aghamiri; M Kahani; R Jaberi
Journal:  Int J Nanomedicine       Date:  2019-06-06

10.  Radio-enhancement effects by radiolabeled nanoparticles.

Authors:  Yaser Hadi Gholami; Richard Maschmeyer; Zdenka Kuncic
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.